Skip to content

AVF Médical

Active
Private limited companyfounded 2022active for 3 yearsRoute de Merbes(BUV) 316, 7133 Binche, BelgiumKBO/BCE: BE 0794.613.409
Summary

AVF Médical has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €191,232 and a net result of €42,835. Equity has been growing by about 37% per year since 2023. Its solvency ranks better than 38% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 09-12-2022 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment units
2.339.169.252 7133 Binche, since 09-12-2022
2.392.422.945 6567 Merbes-le-Château, since 01-01-2026
Financial year end
31 December
Peppol
Reachable since 16-12-2025

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€120,573
▼ 9.9%
Turnover
≈ €220,000
estimated
Profit
€42,835
▼ 36.0%
Equity
€191,232
▲ 28.9%
Total assets
€399,822
▲ 15.4%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.36, cash €142,715Size: total assets €399,822Figures for financial year 2025 (filed on 24-06-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 52% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 73+5
equity 47.8% of total assets
Liquidity 85+3
short-term debt 24.7% · cash 35.7%
Profitability 82-11
return on assets 10.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025highest value 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €17,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.36 (1.77 in 2024), above the usual 1.5. Short-term debt is 24.7% and cash 35.7% of total assets. However, 52.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 38% of them on solvency, 68% on liquidity, 30% on profitability and 71% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.36, cash €142,715
NBB · annual accounts
lowers risk · Size: total assets €399,822
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 24-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-06-2026, 37 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
37 days early
2024
38 days early
2023
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 16 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 June (3 of the last 3 accounts filed within 65 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Recent changes

  1. · Gazette deed Registered office moved from Binche to Buvrinnes
  2. · Gazette deed IncorporationStarting capital €3,000 · Appointment: FÉLIX Julien Rodrigue Emmanuelle (director)
All 8 events

Comparable companies

These companies have the same main activity as AVF Médical: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €370,000 and €470,000, founded between 2022 and 2023.

CompanyTotal assetsGross margin
AVF Médical Binche€399,822€120,573
JCmed Ham-sur-Heure-Nalinnes€419,744€115,733
Dr. Laure Dequeker Kortrijk€388,046€126,188
DR RINGOIR ANNELIES Gent€369,916€115,731
Dr. S. DESMET Eeklo€419,750€132,750
Margot Berings NKO Destelbergen€397,404€135,159
International Breast Clinic Kortrijk€470,093€122,175
Full comparison

Key facts about AVF Médical

What is the company number of AVF Médical?
The company number of AVF Médical is 0794.613.409. The VAT number is the same number with BE in front: BE 0794.613.409.
Where is AVF Médical based?
The registered office is at Route de Merbes(BUV) 316, 7133 Binche.Company details
What does AVF Médical do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of AVF Médical?
The legal form of AVF Médical is Private limited company (BV).
When was AVF Médical founded?
AVF Médical was founded on 09-12-2022.
Is AVF Médical still active?
Yes, AVF Médical is an active enterprise in the KBO register.
What is the turnover of AVF Médical?
The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €120,573 and 43 comparable companies (NACE 86220). It probably lies between €190,000 and €300,000.Financials
Is AVF Médical profitable?
In financial year 2025, AVF Médical made a profit of €42,835.
Where can I find the annual accounts of AVF Médical?
AVF Médical filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of AVF Médical due?
AVF Médical must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.